<HashMap><database>GEO</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Other>ftp://ftp.ncbi.nlm.nih.gov/geo/series/GSE328nnn/GSE328508/</Other></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Transcriptomics</omics_type><species>Homo sapiens</species><gds_type>Expression profiling by high throughput sequencing</gds_type><full_dataset_link>https://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE328508</full_dataset_link><repository>GEO</repository><entry_type>GSE</entry_type></additional><is_claimable>false</is_claimable><name>High-throughout sequencing of ovarian cancer cells treated with T-oligo</name><description>After treating human ovarian cancer cells ES2 with T-oligo G4+RHPS4, high-throughput sequencing technology was employed. The transcriptome analysis revealed that T-oligo G4+RHPS4 does not exert its anti-tumor effect solely through telomere dysfunction, but instead simultaneously regulates cell cycle, senescence, and metabolic-related signaling pathways, thereby synergistically inducing the death of ovarian cancer cells.</description><dates><publication>2026/04/23</publication></dates><accession>GSE328508</accession><cross_references><GSM>GSM9684555</GSM><GSM>GSM9684554</GSM><GSM>GSM9684553</GSM><GSM>GSM9684552</GSM><GSM>GSM9684551</GSM><GSM>GSM9684550</GSM><GPL>24676</GPL><GSE>328508</GSE><taxon>Homo sapiens</taxon></cross_references></HashMap>